(12) United States Patent (10) Patent No.: US 9,173,900 B2 Karpf (45) Date of Patent: Nov
Total Page:16
File Type:pdf, Size:1020Kb
US009 173900B2 (12) United States Patent (10) Patent No.: US 9,173,900 B2 Karpf (45) Date of Patent: Nov. 3, 2015 (54) COMPOSITIONS COMPRISINGELEMENTAL (56) References Cited METALS U.S. PATENT DOCUMENTS (75) Inventor: Gary Karpf, Princeton, NJ (US) 3,791,801 A * 2/1974 Ariga et al. ................... 428,639 4,123,511 A 10, 1978 Heintze (73) Assignee: Prezacor, Inc., Princeton, NJ (US) 4454,118 A 6, 1984 Johnson 4,706,672 A * 1 1/1987 Jones ............................ 607 112 (*) Notice: Subject to any disclaimer, the term of this 4,891,394 A 1/1990 Savin patent is extended or adjusted under 35 5,144,529 A * 9/1992 Takahashi ..................... 361/323 5,148,862 A * 9/1992 Hashiura et al. ... 165,134.1 U.S.C. 154(b) by 1748 days. 5, 182,171 A * 1/1993 Aoyama et al. ............... 428,623 6,017,553 A 1/2000 Burrell et al. (21) Appl. No.: 11/921,477 6,171,606 B1 1/2001 Lyons 6,264,681 B1* 7/2001 Usui ............................. 607 111 (22) PCT Filed: Jun. 5, 2006 6,533,963 B1* 3/2003 Schleifstein et al. ... 252/511 6,884,314 B2 * 4/2005 Cross et al. ................... 156,329 (86). PCT No.: PCT/US2O06/021823 2004/O135997 A1 7/2004 Chan et al. 2004/0210289 A1 * 10/2004 Wang et al. ................... 607,116 S371 (c)(1), (2), (4) Date: Oct. 9, 2009 FOREIGN PATENT DOCUMENTS CN 1486726 A 4/2004 (87) PCT Pub. No.: WO2006/133134 DE 1947222 A1 4f1971 PCT Pub. Date: Dec. 14, 2006 EP O928 611 A1 7, 1999 GB O3711 A Of 1907 (65) Prior Publication Data GB 309394 A 4f1929 GB 98.1372 A 1, 1965 US 2011 FO117179 A1 May 19, 2011 GB 2307862 A 6, 1997 JP 58222011 A 12/1983 JP 2-275823 11, 1990 JP 4-2365 1, 1992 Related U.S. Application Data JP 6-93.63 1, 1994 JP 7-16301 1, 1995 (60) Provisional application No. 60/687,179, filed on Jun. JP O7-059867 3, 1995 3, 2005. JP 2003-137731 A 5, 2003 JP 2004-035440 A 2, 2004 (51) Int. Cl. RU 2123329 C1 12/1998 A6 IK 9/14 (2006.01) WO WO97/2O549 A1 6, 1977 WO WOO1/475O2 A1 T 2001 A6 IK33/24 (2006.01) WO WO 2005/023206 A2 3, 2005 AOIN 25/26 (2006.01) WO WO 2005/023213 A1 3, 2005 A6 IK9/00 (2006.01) WO WO 2005/023361 A2 3, 2005 A6 IK 9/16 (2006.01) A 6LX 9/70 (2006.01) * cited by examiner A6 IK33/26 (2006.01) A6 IK33/30 (2006.01) A6 IK33/34 (2006.01) Primary Examiner — Johann R Richter A6IL 15/18 (2006.01) Assistant Examiner — Danielle Sullivan A6IL 5/44 (2006.01) (74) Attorney, Agent, or Firm — Stradley Ronon Stevens & A61 K9/51 (2006.01) Young, LLP (52) U.S. Cl. CPC ................ A61 K33/24 (2013.01): A0IN 25/26 (2013.01); A61 K9/0014 (2013.01); A61 K (57) ABSTRACT 9/1617 (2013.01); A61 K9/7023 (2013.01); A6 IK33/26 (2013.01); A61 K33/30 (2013.01); The invention provides compositions and devices for altering A61 K33/34 (2013.01); A61L 15/18 (2013.01); biological field effects and methods for their use in therapeu A61L 15/44 (2013.01); A61 K9/5 123 (2013.01); tic and agricultural applications. In particular, the invention A61 L 2300/102 (2013.01); A61L 2300/41 provides compositions including one or more elemental met (2013.01); A61 L 2300/624 (2013.01) als coated with one or more non-conducting or semi-conduct (58) Field of Classification Search ing materials and methods for their application to animals CPC ... A61K 2300/00; A61 K33/00; A61K 47/O2: (including humans) and/or plants. A61K9/5115; A61 K9/5192 USPC .................................. 424/420, 421, 485, 502 See application file for complete search history. 34 Claims, 1 Drawing Sheet U.S. Patent Nov. 3, 2015 US 9,173,900 B2 GRAPHCREPRESENTATION (NOT TO SCALESIZE OR NUMBER) ORGANICLAYER MEALLEC PARTICLE US 9,173,900 B2 1. 2 COMPOSITIONS COMPRISINGELEMENTAL to the elemental metal particles. The coating may be mixed or METALS applied in a viscous, liquid, or aerosol form. It should be appreciated that a matrix may include a combination of solid RELATED APPLICATIONS particles and coating(s). The resulting composition may be a dry, viscous, or wet composition depending on the intended This application is a national stage filing under 35 U.S.C. use. For example, the composition may be a solid, liquid, S371 of PCT International application PCT/US2006/021823, grainy, semi-solid, waxy, oily, or watery composition com filed Jun. 5, 2006, which claims priority under 35 U.S.C. prising elemental metal particles at least Some of which are S119(e) from U.S. provisional application Ser. No. 60/687, separated from each other by a matrix of non-conducting 179 filed Jun. 3, 2005, the entire content of which is incorpo- 0 and/or semi-conducting material. According to one aspect of rated by reference herein. the invention, the separation of the conducting elemental metal particles produces certain electrical (e.g., electro FIELD OF THE INVENTION chemical) properties that can interact with living biological Aspects of the invention relate to topical compositions that 15 systems and alter the nature and/or magnitude (e.g., intensity, affect biological processes. In particular, aspects of the inven speed, etc.) of certain biological processes. It should be tion relate to topical compositions for treating injuries, dis appreciated that the nature, dimensions, and relative amounts eases, and pain in animals including humans. Aspects of the of the elemental metal and the matrix materials may alter the invention also relate to topical compositions that modify cer electrical properties of a composition and may be optimized tain features of plant physiology. 2O for a particular biological application. Accordingly, one aspect of the invention provides a bio BACKGROUND logically active elemental metal composition including one or more elemental metal particles within a matrix of non Creams and ointments containing certain metals have been conducting or semi-conducting material. In one embodiment, used on humans and other animals as protective materials 25 the matrix may be a coating material that is disposed around (e.g., Sun creams) and for treating a variety of ailments (e.g., at least a fraction of the Surface area of the particulate elemen rashes and infections). Examples include creams containing tal metal(s). In one embodiment, the matrix may be a particu copper Sulfate. late material that is mixed with the elemental metal particles and that separates at least a fraction of the elemental metal SUMMARY 30 particles from each other. For example, the material may be a Aspects of the invention provide compositions comprising semi-conducting material. The matrix material may be a sili one or more elemental metals and methods of their use for con dust, Sulfur, boron, fiberglass, or other Suitable material. impacting biological processes in animals and/or plants. In another aspect, the invention provides a solid biologi Aspects of the invention are based, in part, on the discovery 35 cally active elemental metal composition including elemental that certain configurations of elemental metals have Surpris metal Volumes dispersed within a solid matrix of non-con ing effects on many biological processes. In particular, com ducting and/or semi-conducting material. positions comprising one or more elemental metal structures Aspects of the invention include using one or more elemen that are mixed and/or coated with one or more non-conduct tal metal compositions to impact one or more biological pro ing and/or semi-conducting materials may have significant 40 cesses. An elemental metal composition may be used in an therapeutic and/or agricultural uses. According to aspects of amount and for a time Sufficient to obtain a particular biologi the invention, certain elemental metal compositions may cal outcome. Biological applications include medical, Veteri interact with electrical fields (e.g., electrostatic and/or elec nary, and agricultural applications as described herein. It tromagnetic fields) associated with living biological systems should be appreciated that different amounts and or exposure (e.g., cells, tissue, organs, organisms, etc.) and this interaction 45 times may be appropriate for different applications. Effective can be used to alter certain biological processes. In contrast to and/or optimal compositions and exposure conditions (in compositions that deliver metalions for direct chemical inter cluding amount and/or time of exposure) may be determined actions with biological processes and molecules, aspects of for any particular application based on the description and the present invention provide compositions with electrostatic examples provided herein. and/or electromagnetic properties that may impact a biologi- 50 cal system indirectly through electrostatic and/or electromag In some embodiments, the invention provides a body Sur netic field effects that do not require direct contact with the face (external) appliance or device constructed to fit a certain biological system. Accordingly, although compositions of the body part and containing a compound that is specifically invention may be applied to a biological Surface (e.g., skin) in formulated to consist of microscopic capacitors that respond the form of a cream or ointment, compositions of the inven- 55 to and resonate with naturally occurring electrical fields (e.g., tion also may be effective when put in close proximity with a fields of nerve and/or body tissue). biological Surface (e.g., the composition may be in an enclo Accordingly, aspects of the invention may include non Sure or container that is placedonor near a biological system).